CIK 0001094038
- Non-accelerated filer
- Smaller reporting company
Marker Therapeutics, Inc.
Sign in to watch- Ticker
- MRKR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880277072
- Phone
- +1 713-400-6400
- Business address
- 2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
- Former names
- TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-17 | ELMS STEVE Director | Grant or award · Stock Option (right to buy) | +84,411 | 84,411 | ||
| 2025-11-17 | ELMS STEVE Director | Grant or award · Stock Option (right to buy) | +137,330 | 137,330 | ||
| 2025-02-12 | ELMS STEVE Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-12-23 | ELMS STEVE Director | Purchase | +11,085 | $3.20 | $35K | 325,370 |
| 2023-06-06 | ELMS STEVE Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2022-05-24 | ELMS STEVE Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2021-06-08 | ELMS STEVE Director | Grant or award | +12,658 | 29,680 | ||
| 2021-03-16 | ELMS STEVE Director | Purchase | +1,142,857 | $1.75 | $2.0M | 3,142,857 |
| 2019-08-06 | ELMS STEVE Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 |
Page 1 of 1 · 9 trades